Skip to main content

Priority-driven Collaborative Cancer Research Scheme

A A

Cancer Australia has established the Priority-driven Collaborative Cancer Research Scheme to support research that reduces the impact of cancer on the community and improves outcomes for people affected by cancer.

Overview

The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders to collaboratively fund cancer research in Australia.

This funding scheme helps to:

  • coordinate funding of priority-driven cancer research at the national level,
  • foster collaboration between cancer researchers to build Australia’s cancer research capacity, and
  • foster consumer participation in cancer research, from design to implementation.

Working with the National Health and Medical Research Council (NHMRC)

This research scheme is managed by Cancer Australia and the agency collaborates with the NHMRC in this grant scheme. The NHMRC facilitates registration and initial assessment of applications, and endorses grants funded through this scheme in recognition of their scientific merit.

Successful applicants for 2019 Round

The Australian Government is proud to announce the successful applicants in the 2019 round of the Priority-driven Collaborative Cancer Research Scheme (PdCCRS), funded by Cancer Australia, Australian Lions Childhood Cancer Research Foundation, Cure Cancer, Leukaemia Foundation, My Room, National Breast Cancer Foundation, and The Kids’ Cancer Project.

Successful grants in the 2019 PdCCRS round are as follows:

Bock, Nathalie
Queensland University of Technology
Bioengineered humanised models: A novel preclinical platform for bone metastatic cancer research
Funded by: Cancer Australia and Cure Cancer

Brooks, Kelly
The Council of the Queensland Institute of Medical Research
Investigating poly-ADP ribose polymerase inhibitors (PARP) for the treatment of splicing factor 3b subunit 1 (SF3B1) mutant melanoma
Funded by: Cancer Australia and Cure Cancer

Campbell, Ian
Peter MacCallum Cancer Centre
Integrative approaches to identifying the causes of familial breast cancer
Funded by: Cancer Australia and National Breast Cancer Foundation

Cantley, Melissa         
The University of Adelaide
Using novel high-precision proteomic analysis to discover biomarkers that identify smouldering myeloma patients at high-risk of progression to active multiple myeloma
Funded by: Cancer Australia, Cure Cancer, and Leukaemia Foundation

Care, Andrew
Macquarie University
“Cage fighting" with neuroblastoma: Engineering a protein nanocage for targeted ionophoric-copper therapy
Funded by: Cancer Australia, The Kids’ Cancer Project, and Australian Lions Childhood Cancer Research Foundation

Cheung, Laurence
Telethon Kids Institute
New therapeutic strategies for children with high-risk leukaemia by dissecting and targeting the bone marrow microenvironment
Funded by: Cancer Australia, Cure Cancer, and Leukaemia Foundation

Da Gama Duarte, Jessica

Olivia Newton John Cancer Research Institute
Predicting immunotherapy treatment outcomes in rare cancers
Funded by: Cure Cancer

Deng, Niantao
The Garvan Institute of Medical Research
Understanding breast cancer patients’ response to neoadjuvant chemotherapy at single-cell resolution
Funded by: Cure Cancer

Ebert, Lisa
Central Adelaide Local Health Network
Predicting and improving anti-tumour responses to immunotherapy in advanced cancer patients
Funded by Cancer Australia

Emery, Jon      
University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre
SCRIPT: an RCT of genomic-based stratified colorectal cancer screening in primary care
Funded by: Cancer Australia

Haber, Michelle          
Children's Cancer Institute
Enhanced polyamine depletion as a novel therapy for aggressive childhood cancers
Funded by: Cancer Australia and The Kids’ Cancer Project

Hao, Marlene
University of Melbourne
A gut feeling about new therapies for glioma research: lessons from the enteric nervous system
Funded by: Cure Cancer

Holien, Jessica
St Vincent’s Institute of Medical Research
Identification of novel therapeutic targets in mucinous ovarian cancer
Funded by: Cure Cancer

Hollande, Frederic      
University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre
The preclinical validation of radio-labelled girentuximab as a theranostic agent in metastatic colorectal cancer
Funded by: Cancer Australia

Horvath, Lisa
Chris O’Brien Lifehouse
Immuno-metabolic biomarkers to predict treatment response in metastatic prostate cancer
Funded by: Cancer Australia

Kavallaris, Maria
Children's Cancer Institute
Functional precision medicine for aggressive childhood cancers
Funded by: Cancer Australia

Keall, Paul       
University of Sydney
Remove the mask: reducing anxiety and distress for head and neck cancer radiotherapy patients
Funded by: Cancer Australia

Kulasinghe, Arutha
Queensland University of Technology
Multidimensional spatial profiling of the tumour microenvironment and liquid biopsy to determine response to immunotherapy
Funded by: Cure Cancer

Lesterhuis, Willem
Telethon Kids Institute
Intraoperative immunotherapy to prevent relapse in soft tissue sarcoma
Funded by: Cancer Australia and The Kids’ Cancer Project

Li, Shuai
University of Melbourne
Integrating epigenomics and genomics to understand the causal pathways and mechanisms of how menarche and menopause modify breast cancer risk
Funded by: Cure Cancer

McCarroll, Joshua
Children's Cancer Institute
Application of gene-silencing nanodrugs to inhibit medulloblastoma growth
Funded by: Cancer Australia and The Kids’ Cancer Project

McGovern, Jacqui
Institute of Health and Biomedical Innovation
Humanized rat models - the next frontier in pre-clinical osteosarcoma research
Funded by: Cancer Australia and My Room

Merlot, Angelica
Lowy Cancer Research Centre
Targeting the endoplasmic reticulum stress pathways against cancer
Funded by: Cure Cancer

Nassar, Natasha
The Children's Hospital at Westmead Clinical School
Life and health after childhood cancer: a national data linkage cohort study
Funded by: Cancer Australia

Park, Simone
Peter Doherty Institute for Infection & Immunity
Targeting tissue-resident memory T cells in cancer immunotherapy
Funded by: Cancer Australia and Cure Cancer

Segelov, Eva   
Monash Medical Centre
ASCOLT: ASpirin for Dukes C and high risk B COLorecTal cancer. An international, multi-centre, double blind, randomised trial
Funded by: Cancer Australia

Tanwar, Pradeep
The University of Newcastle
Obesity epidemic fuelling the surge of endometrial cancers: Elucidating the role and targeting of molecular signals involved in fat and endometrial cancer cross-talk
Funded by: Cancer Australia

Thijssen, Rachel
The Walter and Eliza Hall Institute of Medical Research
Developing strategies to overcome venetoclax resistance in chronic lymphocytic leukaemia
Funded by: Cancer Australia and Cure Cancer

Ward, Paul
Flinders University
Increasing resilience and reducing smoking for lower socio-economic groups
Funded by Cancer Australia

Cancer Australia, Susan G. Komen and Worldwide Cancer Research are pleased to announce funding of the following projects in the 2019 Priority-driven Collaborative Cancer Research Scheme international.

Dawson, Sarah-Jane
Peter MacCallum Cancer Centre
Genomic and epigenomic monitoring of residual disease using liquid biopsies
Funded by: Cancer Australia with the support of Susan G. Komen

O’Keeffe, Meredith
Monash University
Checkpoint receptors expressed by dendritic cells- do they play a role in immunotherapies?
Funded by: Cancer Australia and Worldwide Cancer Research

Cancer Australia's funding partners and successful applicants in previous PdCCRS rounds

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Find out more about: